Summit Therapeutics Inc. Common Stock

SMMT

...

SMMT: Summit Therapeutics Inc is a biopharmaceutical company that focuses on the discovery, development, and commercialization of novel antibiotics for serious infectious diseases. Its lead CDI (Clostridiodes difficile infection) product candidate is ridinilazole, an orally administered small molecule antibiotic. It has two geographical segments: the United States and the United Kingdom.

Show SMMT Financials

All

Government

Consumer Interest

SEC Filings

ESG/Other

Congress Trading

Recent trades of SMMT by members of U.S. Congress

No Congress Trading data for this ticker

Congress Trading Dashboard

Whale Activity

Recently reported changes by institutional investors

Insider Trading

Quarterly net insider trading by SMMT's directors and management

Corporate Lobbying

Government lobbying spending instances

$30,000 Aug 03, 2020 Issue: Pharmacy

U.S. Patents

New patents grants

Patent Title: Antibacterial compounds Sep. 19, 2017
Patent Title: Antibacterial compounds Apr. 19, 2016
Patent Title: Compounds for the treatment of Mar. 08, 2016

Government Contracts

Federal grants, loans, and purchases

No Government Contracts for this ticker

Government Contracts Dashboard

Twitter

Followers on SMMT's company Twitter account

WallStreetBets

Number of mentions of SMMT in WallStreetBets Daily Discussion

SMMT News

Recent insights relating to SMMT

CNBC Recommendations

Recent picks made for SMMT stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in SMMT

Corporate Flights

Flights by private jets registered to SMMT